Photo by nci from unsplash
Immunotherapy has limited success in triple-negative breast cancer (TNBC). In this issue of Cell Metabolism, Wang et al. found that microbial metabolite TMAO boosts CD8+ T cell-mediated antitumor immunity by inducing pyroptosis… Click to show full abstract
Immunotherapy has limited success in triple-negative breast cancer (TNBC). In this issue of Cell Metabolism, Wang et al. found that microbial metabolite TMAO boosts CD8+ T cell-mediated antitumor immunity by inducing pyroptosis in tumor cells, enhancing the efficacy of immunotherapy in TNBC (Wang et al., 2022).
Keywords:
immunotherapy;
icebreaker immunotherapy;
cell;
microbial metabolite;
metabolite icebreaker
Journal Title: Cell metabolism
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cell metabolism
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!